Abstract
The average normal incidence of thrombophlebitis in nonpregnant women of childbearing age is one case per 1,000 women per year based on data from hospital admissions, and 2.2 cases per 1,000 women per year based on data from visits to the physician. The antepartum incidence is 0.5 cases per 1,000 women per nine months. In studies with oral contraceptives, the average incidence was 0.5 cases per 1,000 women per year. Evidence does not indicate that the administration of oral contraceptives to women with a history of thrombophlebitis increases the chance of recurrence of the disease. Data in the United States do not demonstrate an increase in death rate from pulmonary embolism, and vital statistics for England do not show an increase in the ratio of women to men dying from thromboembolic diseases since the introduction of oral contraceptives.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
